IL-1β contributes to the secretion of sclerostin by osteocytes and targeting sclerostin promotes spinal fusion at early stages
Open Access
- 3 March 2023
- journal article
- research article
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 18 (1) , 1-13
Abstract
Background: Despite extensive research, there is still a need for safe and effective agents to promote spinal fusion. Interleukin (IL)-1β is an important factor which influences the bone repair and remodelling. The purpose of our study was to determine the effect of IL-1β on sclerostin in osteocytes and to explore whether inhibiting the secretion of sclerostin from osteocytes can promote spinal fusion at early stages. Methods: Small-interfering RNA was used to suppress the secretion of sclerostin in Ocy454 cells. MC3T3-E1 cells were cocultured with Ocy454 cells. Osteogenic differentiation and mineralisation of MC3T3-E1 cells were evaluated in vitro. SOST knock-out rat generated using the CRISPR-Cas9 system and rat spinal fusion model was used in vivo. The degree of spinal fusion was assessed by manual palpation, radiographic analysis and histological analysis at 2 and 4 weeks. Results: We found that IL-1β level had a positive association with sclerostin level in vivo. IL-1β promoted the expression and secretion of sclerostin in Ocy454 cells in vitro. Inhibition of IL-1β-induced secretion of sclerostin from Ocy454 cells could promote the osteogenic differentiation and mineralisation of cocultured MC3T3-E1 cells in vitro. The extent of spinal graft fusion was greater in SOST-knockout rats than in wild-type rats at 2 and 4 weeks. Conclusions: The results demonstrate that IL-1β contributes to a rise in the level of sclerostin at early stages of bone healing. Suppressing sclerostin may be an important therapeutic target capable of promoting spinal fusion at early stages.Keywords
Funding Information
- National Natural Science Foundation of China (81801375, 82001471)
This publication has 40 references indexed in Scilit:
- A novel library screen identifies immunosuppressors that promote osteoblast differentiationBone, 2012
- Wnt Inhibition Correlates with Human Embryonic Stem Cell Cardiomyogenesis: A Structure–Activity Relationship Study Based on Inhibitors for the Wnt ResponseJournal of Medicinal Chemistry, 2011
- A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learnedThe Spine Journal, 2011
- Complications and Concerns With Osteobiologics for Spine Fusion in Clinical PracticeSpine, 2010
- Biofilm Detection With Hematoxylin-Eosin StainingJAMA Otolaryngology–Head & Neck Surgery, 2010
- Action of IL‐1β during fracture healingJournal of Orthopaedic Research, 2010
- The Small Molecule Phenamil Induces Osteoblast Differentiation and MineralizationMolecular and Cellular Biology, 2009
- A Small Molecule with Osteogenesis-Inducing Activity in Multipotent Mesenchymal Progenitor CellsJournal of the American Chemical Society, 2002
- Protein Expression and Functional Difference of Membrane-Bound and Soluble Receptor Activator of NF-κB Ligand: Modulation of the Expression by Osteotropic Factors and CytokinesBiochemical and Biophysical Research Communications, 2000
- The expression of cytokine activity by fracture callusJournal of Bone and Mineral Research, 1995